10 May 2010 in Asian Journal of Communication
This article provides a critical review of intercultural communication research in or on ‘Asia’ over the past 20 years. Intercultural communication became a noticeable sub-area of Asian communication studies only in the 1990s. Awareness of Asian intercultural communication scholarship has been hampered by the limited number of Asian countries that have generated relevant research. In recent years, however, there have been some major developments of the landscape in intercultural communication contributed by Asian scholars. First, this review will discuss the development of the academic field of intercultural communication in Asia. Then, I point out three commonly shared challenges of intercultural communication research in the region. First, the cultural level analyses (e.g., accounts of Asian communication styles) tend to paint all ‘Asians’ with the same broad brush as collectivistic, and thus reserved and indirect. Second, some argue that the representation of Asian communication systems in intercultural communication literature functions partly to ‘manage’ and ‘perpetuate’ power relations between the West and non-West. Third, there is a growing awareness of the limitations of intercultural communication theories so steeped in Eurocentrism that they oversimplify the complexity of the ‘rest of the world’. In dealing with these challenges, recent research trends in intercultural communication in Asia call attention to: (1) the complexity and increasing heterogeneity of Asian communication styles; (2) the traditions of Asia as sources of concepts in intercultural communication; and (3) the reconsideration of the Western research paradigm. This review discusses the possibilities and challenges we face, thus contributing to a better awareness and understanding of intercultural communication research in Asia.
16 February 2012 in AI & SOCIETY
1 January 2015 in Annals of Pediatric Endocrinology & Metabolism
Increasing evidence suggests an important role of the insulin-like growth factor (IGF)-IGF binding protein (IGFBP) axis in the maintenance of normal glucose and lipid metabolism. Significant changes occur in the local IGF-I-IGFBPs environment in response to the diabetic milieu. A significant reduction of serum IGF-I levels was observed in patients with type 1 diabetes mellitus (T1DM). Inversely, considerably increased serum levels of IGF-I and IGFBP-3 levels were detected in individuals with glucose intolerance including T2DM. Recently, several prospective studies indicated that baseline levels of IGF-I and IGFBPs are associated with the development of diabetes. These findings suggest that disturbances in insulin and IGF-I-IGFBP axis can affect the development of glucose intolerance including diabetes.
9 April 2012 in Toxicology Mechanisms and Methods
SASankarganesh Arunachalam
+1
Adriamycin is an anti-cancer drug, effective against a wide range of cancers. However, its clinical application is limited by its cardiotoxicity. A number of reports suggest that adriamycin induces bodyweight loss also. The aim of this study was to investigate the effect of adriamycin on adipogenesis as bodyweight chancges can be directly correlated with adipocytes. Fat accumulation in 3T3-L1 pre-adipocytes, as a result of adipogenesis was detected using oil red O staining. We performed western immunoblot for the expression of adipocyte differentiation related genes to analyze the molecular mechanism of adriamycin-mediated inhibition of adipogenesis. Over-expression of target gene was done by using recombinant adenoviruses. Adriamycin inhibited adipogenesis in a dose-dependent manner. It was observed that adriamycin down-regulated the expression of PPARγ. Moreover, up-stream elements of PPARγ were also found to be down-regulated by adriamycin. Adriamycin might prevent bodyweight gain through inbibition of adipogenesis by the down-regulation of PPARγ and its up-stream transcriptional regulators like C/EBPβ and KLF4. To reverse the adriamycin-mediated inhibition of adipogenesis, PPARγ was over-expressed by adenoviral mediated gene delivery. Over-expression of PPARγ partially restored adipogenesis. Moreover, the early regulators of adipogenesis were also found to be restored after the over-expression of PPARγ. Adriamycin down-regulates the expression of PPARγ which leads to prevention of bodyweight gain through inhibition of adipogenesis. Activation of PPARγ by either adenoviral mediated gene delivery or by using PPARγ agonist may be useful in controlling the bodyweight loss.
29 November 2007 in Journal of Intercultural Communication Research
Intercultural communication scholarship is poised to be a powerful force in the communication field as well as social sciences in general. In this paper, we focus on four main areas which we hope will spur creative academic inquiry in the future. More productive efforts will move beyond the ethnocentrism that permeates current communication research and will entail a thorough redefinition of personhood. Future work will move beyond discussions of how cultures assimilate to include how other cultures interact in a host culture to sustain multiple cultural identities. Additionally, research will move beyond examining linguistic and cultural differences, to also recognize the social-action nature of communication. Finally, future endeavors will move beyond the study of culture-typed identities and question the very notion of cultural boundaries. We predict that the inevitable challenges posed by multiculturalism will allow intercultural communication studies to play a more central role as an interdisciplinary “clearing-house” within the social sciences.
30 September 2018 in Annals of Pediatric Endocrinology & Metabolism
Alpha-1 antitrypsin (AAT), an alpha globulin glycoprotein, is a member of the serine protease inhibitor (serpin) superfamily. The clinical significance of AAT is highlighted by AAT deficiency. Genetic deficiency of AAT can present as several neutrophilic diseases associated with emphysema, liver cirrhosis, panniculitis, and systemic vasculitis. Recently, animal and human studies have shown that AAT can control inflammatory, immunological, and tissue-protective responses. In addition, AAT treatment can prevent overt hyperglycemia, increase insulin secretion, and reduce cytokine-mediated apoptosis of pancreatic β-cells in diabetes. These multifunctional roles of AAT draw attention to the glycoprotein's therapeutic potential for many inflammatory and autoimmune diseases beyond AAT deficiency. As underlying mechanisms, recent studies have suggested the importance of serine protease inhibitory activity of AAT in obesity-associated insulin resistance, chronic obstructive pulmonary disease, and cystic fibrosis. In this review, we explore the multiple functions of AAT, in particular, the anti-inflammatory and serine protease inhibitory functions, and AAT's therapeutic potential in a variety of human diseases through published literature.